Ozempic vs Wegovy for weight loss: which do online clinics prescribe more easily?

Short answer

• Online clinics most commonly prescribe Ozempic (semaglutide formulated/marketed for type 2 diabetes) more easily/off-label for weight loss because it’s more widely available, has broader prescribing familiarity, and is often covered when used for diabetes.
• Wegovy (the higher‑dose semaglutide FDA‑approved specifically for chronic weight management) is prescribed by many telehealth weight‑loss programs, but it’s often harder to get because of stricter eligibility, supply/cost issues, and more limited insurance coverage.

Why (brief)

• Indication and packaging: Ozempic is approved for T2D; clinicians can prescribe it off‑label for weight loss. Wegovy is the approved obesity product (2.4 mg weekly) and therefore requires the clinic to document obesity‑specific eligibility (BMI criteria, medical history).
• Availability and cost: Wegovy has been subject to supply limits and is more expensive; insurers are inconsistent about covering it. That makes many clinicians and patients opt for Ozempic or alternatives.
• Clinical practice: Primary‑care and broad telehealth providers often prescribe Ozempic off‑label. Specialized obesity programs are more likely to pursue Wegovy when appropriate.

Where people tend to get each drug (examples)

• Ozempic (easier via general telehealth/primary care)
  • PlushCare, Teladoc, Amwell — general telemedicine platforms where primary‑care clinicians commonly prescribe semaglutide after evaluation.
  • Hims & Hers, Ro (Roman) — direct‑to‑consumer telehealth companies that have offered semaglutide prescriptions for weight loss.
  • Local PCP via an online visit — many PCPs will prescribe Ozempic if they’re comfortable with off‑label use.
• Wegovy (more common at specialized weight‑loss programs)
  • Calibrate — a well‑known metabolic/weight‑loss program that integrates coaching and medical management and will pursue Wegovy when you meet criteria.
  • Other dedicated obesity clinics (online or hybrid) that advertise obesity treatment and GLP‑1 management will be the places more likely to prescribe Wegovy.

Practical tips

• Ask the clinic up front: “Do you prescribe Wegovy (2.4 mg semaglutide) or do you prescribe Ozempic off‑label for weight loss?” Ask about eligibility, price, insurance billing, labs, and follow‑up.
• If you have type 2 diabetes, Ozempic is usually easier to get and more likely to be covered.
• If you don’t have diabetes and want the FDA‑approved weight‑loss product, expect to work with a specialty weight‑loss program, potentially pay more, and possibly join a waitlist.
• Safety: both drugs require medical screening (pregnancy risk, pancreatitis history, thyroid cancer risk, etc.) and follow‑up. Don’t start without clinical supervision.

If you’d like, tell me your state, whether you have diabetes, and whether you want the lowest out‑of‑pocket cost or the FDA‑approved weight‑loss product, and I can suggest specific telehealth services that match.